Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AppTec Laboratory Services is a contract research and manufacturing organization (CRO/CDMO) that provides essential testing and production services to the pharmaceutical, biotechnology, and medical device sectors. The company specializes in biologics safety testing, viral clearance, and the manufacturing of advanced therapies, including cell and gene products. Founded in 2001 and headquartered in St. Paul, Minnesota, AppTec established a strong reputation for its technical expertise and regulatory compliance. In 2008, the company was acquired by WuXi PharmaTech (now WuXi AppTec) for approximately $151 million, serving as the foundation for WuXi's extensive U.S.-based operations. Today, its facilities in Minnesota, Pennsylvania, and Georgia are fully integrated into WuXi AppTec's global service platform, supporting clients from early-stage R&D through commercial production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Apptec Laboratory Services.